Acadia Healthcare (NASDAQ:ACHC) Stock Price Down 4.7%

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares were down 4.7% during trading on Wednesday . The company traded as low as $59.25 and last traded at $59.49. Approximately 924,325 shares were traded during mid-day trading, an increase of 7% from the average daily volume of 861,286 shares. The stock had previously closed at $62.41.

Wall Street Analyst Weigh In

A number of research analysts have commented on ACHC shares. Cantor Fitzgerald reiterated a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday. Royal Bank of Canada restated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Friday, September 20th. Barclays reduced their price target on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a report on Monday. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $86.67.

Acadia Healthcare Price Performance

The firm has a market capitalization of $5.46 billion, a P/E ratio of -440.79, a P/E/G ratio of 2.19 and a beta of 1.30. The firm’s 50 day simple moving average is $74.12 and its two-hundred day simple moving average is $71.40. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.18 and a quick ratio of 1.18.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The business’s revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.92 earnings per share. As a group, analysts predict that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors have recently bought and sold shares of the stock. Blue Trust Inc. lifted its holdings in shares of Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the last quarter. Mather Group LLC. purchased a new position in shares of Acadia Healthcare in the 1st quarter worth approximately $48,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Acadia Healthcare during the 2nd quarter worth approximately $59,000. nVerses Capital LLC purchased a new stake in Acadia Healthcare during the 2nd quarter worth approximately $95,000. Finally, Innealta Capital LLC acquired a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $164,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.